Health Care & Life Sciences » Healthcare Provision | Falco Holdings Co. Ltd.

Falco Holdings Co. Ltd. | Income Statement

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
58,401
46,593
48,727
45,971
45,962
44,156
Cost of Goods Sold (COGS) incl. D&A
43,570
33,360
34,652
32,488
32,534
31,590
Gross Income
14,831
13,233
14,075
13,483
13,428
12,566
SG&A Expense
13,260
11,531
11,961
11,321
11,217
11,228
EBIT
1,571
1,702
2,114
2,162
2,211
1,338
Unusual Expense
389
310
91
202
4
371
Non Operating Income/Expense
3,519
514
304
283
461
247
Interest Expense
91
33
15
12
11
9
Pretax Income
4,161
1,874
2,313
2,228
2,658
1,203
Income Tax
1,883
757
966
750
960
550
Consolidated Net Income
2,278
1,117
1,347
1,478
1,697
653
Net Income
2,278
1,117
1,347
1,478
1,697
653
Net Income After Extraordinaries
2,278
1,117
1,347
1,478
1,697
653
Net Income Available to Common
2,278
1,117
1,347
1,478
1,697
653
EPS (Basic)
189.11
98.94
120.41
133.89
156.09
59.76
Basic Shares Outstanding
12
11
11
11
11
11
EPS (Diluted)
189.06
98.94
120.41
133.87
155.62
59.41
Diluted Shares Outstanding
12
11
11
11
11
11
EBITDA
3,085
2,742
3,027
3,024
3,089
2,165
Non-Operating Interest Income
5
1
1
1
1
1

About Falco Holdings Co.

View Profile
Address
346 Shimizu-cho
Kyoto Kyoto 604
Japan
Employees -
Website http://www.falco-hd.co.jp
Updated 07/08/2019
FALCO HOLDINGS Co., Ltd. engages in the provision of clinical testing and dispensing pharmacy services. It operates through the Clinical Testing and Dispensing Pharmacy segments. The Clinical Testing segment offers genetic testing, clinical research and trials, medical information technology, food hygiene, and environmental inspection services.